Antipsychotic dose escalation as a trigger for Neuroleptic Malignant Syndrome (NMS): literature review and case series report

<p>Abstract</p> <p>Background</p> <p>“Neuroleptic malignant syndrome” (NMS) is a potentially fatal idiosyncratic reaction to any medication which affects the central dopaminergic system. Between 0.5% and 1% of patients exposed to antipsychotics develop the condition. Mo...

Full description

Bibliographic Details
Main Authors: Langan Julie, Martin Daniel, Shajahan Polash, Smith Daniel J
Format: Article
Language:English
Published: BMC 2012-11-01
Series:BMC Psychiatry
Subjects:
Online Access:http://www.biomedcentral.com/1471-244X/12/214